Yearly occurrence of Seasonal Hyperacute Panuveitis (SHAPU) outbreaks in Nepal matches the emergence of its causal agent, the moth Gazalina chrysolopha


Abstract

Background

The Seasonal Hyperacute Panuveitis (SHAPU) generally occurs in odd-numbered years across Nepal, and it is associated with exposure to the causal agent, the urticating setae released by the female moths of Gazalina chrysolopha (Lepidoptera, Notodontidae) in the season following the monsoon. This study reports on an outbreak observed in 2024, an even-numbered year that deviates from the expectation.

Methods

A prospective, hospital-based study was conducted on all patients diagnosed with SHAPU in 2024 in a few tertiary-level Nepali eye hospitals based in Kathmandu and Pokhara. Data were collected on patient demographics, geographical distribution, and clinical characteristics. Data on seasonal insect occurrence in even- and odd-numbered years were collected for Nepal from databases and museum collections for a total of 1693 records.

Results

A total of 18 patients were diagnosed with SHAPU in 2024. The outbreak was observed to spread beyond the typical hotspots of the disease in Nepal. The patients’ ages ranged from 2 to 56, with 8 (44.44%) being under 18 years. Patients reported direct or indirect contact with moths and their caterpillars, and the cases were observed between January and June, with a peak in May. The period matches the emergence of the moth in even-numbered years, while in odd-numbered years, the emergence peaks between July and September, as in the SHAPU cases.

Conclusions

The outbreak of SHAPU in 2024 suggests a shift in its typical pattern, raising concerns that the disease may become an annual occurrence, as evidenced by the few cases observed in 2020 and 2022, in contrast to the expected outbreaks in odd-numbered years (2019, 2021, and 2023). The moths of Gazalina chrysolopha emerged earlier in even-numbered years, explaining the earlier occurrence of SHAPU cases. The spread of SHAPU to other parts of Nepal suggests the possibility that the disease may be becoming a major risk throughout the country.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.

  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].